# Documentation Audit

## Current Documentation Status

Phase 1 reviewed Markdown/MDX documentation only. Source code, configuration, packages, schemas, environment files, deployment files, and runtime behavior were intentionally not inspected.

## Files Reviewed

| File | Classification | Decision |
| --- | --- | --- |
| `README.md` | Current developer/product orientation | Rewritten |
| `FRONTEND_IMPROVEMENTS.md` | Frontend roadmap/design/backlog planning | Merged into structured docs and archived |
| `docs/DEPLOYMENT.md` | Deployment/setup planning with unverified claims | Rewritten |

## Main Documentation Problems Found

- Product and implementation claims were mixed together.
- Features were described as available without source-code verification.
- Setup, deployment, security, and compliance instructions sounded production-ready without evidence.
- Frontend planning content contained useful direction but was formatted like implementation-ready code guidance.
- There was no Phase 2 handoff for code verification.
- There was no separation between product vision, roadmap, backlog, design direction, and architecture intent.

## Biggest Sources of Confusion

- The old README listed features, tech stack, testing commands, project structure, security controls, and safety protocols as if confirmed.
- The old deployment guide included config snippets and source-code examples that could cause future agents to edit config/source prematurely.
- The frontend improvements file contained many future ideas with code snippets, dependency suggestions, and tool recommendations that were not prioritized or verified.

## Most Dangerous Misleading Claims Softened

The following claim categories were marked **Unverified until Phase 2 code audit**:

- AI-powered behavior and provider integrations.
- Medical personas and symptom routing.
- Medication-interaction checking.
- Authentication and database-backed user flows.
- Redis caching.
- Analytics dashboards.
- Voice input and PDF export.
- Emergency detection and red-flag monitoring.
- Data encryption, PII filtering, audit logging, HIPAA readiness, GDPR readiness, rate limiting, and production security.
- Test command availability and test coverage.
- Vercel deployment readiness.

## Files Rewritten

- `README.md`: reduced from a confident feature/stack guide to a safe repository orientation and documentation map.
- `docs/DEPLOYMENT.md`: reduced from a production-style guide to deployment planning notes with verification questions and guardrails.

## Files Merged

- `FRONTEND_IMPROVEMENTS.md` was merged into:
  - `docs/ROADMAP.md` for phase sequencing.
  - `docs/PRODUCT_BACKLOG.md` for future feature candidates.
  - `docs/DESIGN_DIRECTION.md` for UX/accessibility/frontend quality direction.
  - `docs/ARCHITECTURE_INTENT.md` for engineering/tooling intent and risks.

## Files Archived

- `docs/archive/FRONTEND_IMPROVEMENTS.md`: preserved as historical context because it contains useful design, frontend, performance, accessibility, testing, and product ideas but should not guide implementation directly.

## Files Deleted

- `FRONTEND_IMPROVEMENTS.md` was removed from the repository root after its useful content was merged and the original was archived.

No Markdown file was deleted without either preserving useful content or intentionally replacing it with safer documentation.

## New Files Created

- `docs/PROJECT_CONTEXT.md`: product context and intended user flows from docs only.
- `docs/PRODUCT_VISION.md`: long-term product direction and principles.
- `docs/ROADMAP.md`: Phase 2-first roadmap and future priorities.
- `docs/PRODUCT_BACKLOG.md`: structured backlog candidates from old feature lists and brainstorming.
- `docs/DESIGN_DIRECTION.md`: frontend, UX, accessibility, and product-quality direction.
- `docs/ARCHITECTURE_INTENT.md`: intended architecture and verification risks.
- `docs/DOCUMENTATION_AUDIT.md`: inventory, diagnosis, and decisions from Phase 1.
- `docs/NEXT_CODE_AUDIT_BRIEF.md`: actionable handoff for Phase 2.
- `docs/archive/FRONTEND_IMPROVEMENTS.md`: historical preservation of the original frontend planning file.

## Product Vision Preserved

Phase 1 preserved the core ambition for:

- AI-assisted health information conversations.
- Specialist/persona-based experiences.
- Citation-supported answers.
- Symptom navigation.
- Medication-interaction exploration.
- Conversation history/export/search/analytics concepts.
- Voice, personalization, PWA, and notifications as future ideas.
- A calm, trustworthy, accessible healthcare UX.
- Safety disclaimers, emergency guidance, and professional referral boundaries.

## Remaining Documentation Risks

Because source code was intentionally not reviewed, these risks remain:

- The cleaned docs may still describe a product direction that differs from actual implementation.
- Setup and deployment instructions remain intentionally non-operational until code/config verification.
- Product vision may need reprioritization after the code audit reveals real implementation constraints.
- Medical, privacy, compliance, and security posture must be verified through code review and expert review.
